GLP-1s

Medicaid spending on opioid overdose-reversal drug naloxone shot up from $110,000 in 2010 to close to $15 million in 2018, according to a study released Aug. 26 by Washington, D.C. think tank the Urban Institute.

UnitedHealthcare is changing which medication for HIV prevention it considers a covered option for members.

Even though opioid overdoses reached their all-time peak in 2019, opioid prescriptions decreased by 37.1 percent from 2014-19, according to the most recent report from the American Medical Association's Opioid Task Force.

About one in five U.S. women reported that they misused prescription opioids during pregnancy, a CDC analysis of survey data shows.

Fentanyl is first on the list of drugs found in overdose patients at University of Maryland Medical Center's midtown and downtown campuses, according to a study published June 12 in the CDC's Morbidity and Mortality Weekly Report.

A diagnostic tool for rapid COVID-19 testing developed by Hackensack (N.J.) Meridian Health's Center for Discovery and Innovation will now be available to other health systems through a licensing agreement announced March 24.

Blue Shield of California is the first health plan to pay for rapid whole genome sequencing for critically ill children so physicians can quickly identify and decode the root causes of rare genetic disorders.

Although use of opioids to treat back pain patients coming to the emergency department decreased overall from 2007 to 2016, the use of one opioid, tramadol, doubled, new research shows, according to MedPage Today.

State laws on opioid prescription volumes may help lower opioid use and positively influence providers' prescribing decisions, according to a study published in JAMA Network Open.

The number of non-cancer patients with chronic pain prescribed an opioid doubled across the globe over 25 years, according to a study published in the Journal of Internal Medicine.